α1 Adrenoceptor subtypes activates Ca2+ movement through stimulating a tyrosine protein kinase pathway in HEK293 cells

Ling Tao,Yongyuan Guan,H. Ge,Hua He,QiDe Han
2000-01-01
Abstract:AIM: To understand whether the tyrosine protein kinase (TPK) pathway is involved in the Ca2+ movement evoked by activation of α1 adrenoceptor subtypes. METHODS: The intracellular Ca2+ concentration ([ Ca2+ ](i)) was measured with Fura-2 probe in transfected HEK293 cells with α(1A), α(1B) and α(1D) adrenoceptor cDNA. The effects of genistein, a TPK inhibitor and U(73122), a phospholipase C(PLC) inhibitor on the response of [Ca2+](i) to activation of different α1 adrenoceptor subtypes by adrenaline(Adr, 10 μmol·L-1) were investigated respectively. RESULTS: Pre-incubated the cells with U(73122) or genistein, the biphasic increase in [Ca2+](i) induced by Adr were inhibited by U(73122)(0.1, 1, 10, 50 μmol·L-1) and genistein (10, 100, 200 μmol·L-1) in a concentration-dependent manner in all transfected HEK293 cells. The [Ca2+](i) response to Adr was fully blocked by U(73122)(50 μmol·L-1) but partly inhibited by maximal effective concentration of genistein (100 μmol·L-1). CONCLUSION: Activation of different subtypes of α1 adrenoceptor induces Ca2+ release and Ca2+ influx through stimulation of TPK protein in HEK293 cells. Both G protein pathway and TPK pathway may be involved in the activation of PLC by α1 adrenoceptor stimulation.
What problem does this paper attempt to address?